Citadel Advisors
ANGO icon

Citadel Advisors’s AngioDynamics ANGO Stock Holding History

Citadel Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,600
Closed -$194K – 12688
2025
Q2 		$194K Buy
19,600
+5,300
+37% +$51.9K ﹤0.01% 10704
2025
Q1 		$134K Buy
14,300
+1,500
+12% +$15.8K ﹤0.01% 11038
2024
Q4 		$117K Buy
12,800
+8,800
+220% +$64.7K ﹤0.01% 11225
2024
Q3 		$31.1K Buy
+4,000
New +$28.9K ﹤0.01% 12403
2024
Q2 		– Sell
-1,400
Closed -$8.22K – 14174
2024
Q1 		$8.22K Buy
+1,400
New +$8.32K ﹤0.01% 13570
2023
Q3 		– Sell
-5,000
Closed -$52.1K – 14237
2023
Q2 		$52.1K Sell
5,000
-9,600
-66% -$92.4K ﹤0.01% 11748
2023
Q1 		$151K Buy
14,600
+14,500
+14,500% +$186K ﹤0.01% 10628
2022
Q4 		$1.38K Buy
+100
New +$1.39K ﹤0.01% 14480
2022
Q2 		– Sell
-10,100
Closed -$218K – 12801
2022
Q1 		$218K Sell
10,100
-9,400
-48% -$213K ﹤0.01% 11312
2021
Q4 		$538K Buy
19,500
+10,200
+110% +$281K ﹤0.01% 9519
2021
Q3 		$241K Buy
+9,300
New +$249K ﹤0.01% 11556
2020
Q2 		– Sell
-20,200
Closed -$211K – 9719
2020
Q1 		$211K Buy
+20,200
New +$254K ﹤0.01% 7921
2018
Q4 		– Sell
-15,100
Closed -$328K – 9043
2018
Q3 		$328K Buy
+15,100
New +$335K ﹤0.01% 7424
2017
Q4 		– Sell
-11,100
Closed -$190K – 7923
2017
Q3 		$190K Buy
+11,100
New +$186K ﹤0.01% 6734

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Citadel Advisors's ANGO Position: Q1 2026 in Review

Citadel Advisors reduced its AngioDynamics (ANGO) stake by 5% in Q1 2026, selling an estimated $27.8K and leaving 48,322 shares worth $549K. The position accounts for ﹤0.01% of the portfolio, ranked #9069.

Citadel Advisors first reported a position in ANGO in Q1 2014 and has held it in 41 quarters since. The position peaked at $7.95M in Q4 2023. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Citadel Advisors held 48,322 shares of AngioDynamics worth $549K as of Q1 2026.
  • Citadel Advisors sold 2,561 AngioDynamics shares in Q1 2026, an estimated $27.8K.
  • AngioDynamics made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9069 holding.
  • Citadel Advisors first reported a position in AngioDynamics in Q1 2014 and has held it in 41 quarters since.
  • Citadel Advisors's AngioDynamics position peaked at $7.95M in Q4 2023.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.